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Supercoiled Plasmids in Borrelia burgdorferi,
the Lyme Disease Agent
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Coumermycin A1 is an inhibitor of DNA gyrase, an enzyme that catalyzes supercoiling of DNA and is
required for bacterial DNA replication. We have investigated the activity of this coumarin antibiotic on Borrelia
burgdorferi, a spirochete and the causative agent of Lyme disease. B. burgdorfieri was more susceptible than
many other eubacteria to coumermycin as well as novobiocin, another coumarin antibiotic; this contrasted with
its relative resistance to the DNA gyrase inhibitors nalidixic acid, oxolinic acid, and ciprofloxacin. Coumer-
mycin at 0.2 ,ug/ml inhibited the growth of B. burgdorferi B31 in BSK II medium. A 100-fold-lower
concentration induced the relaxation of two negatively supercoiled circular plasmids within 2 h. Plasmid
supercoiling was restored within 2 h of removal of coumermycin. These results suggest that B. burgdorferi has
a DNA gyrase and that this enzyme's activity is required for growth. Furthermore, structural analogs of
coumermycin may be considered as treatments for Lyme disease.
Lyme disease, a common tick-borne disorder with a
variety of clinical symptoms (28), is caused by the spirochete
Borrelia burgdorfien (6). The genome of B. burgdorfen is
unusual among eubacteria in that it consists of both cross-
linked linear and supercoiled circular DNA molecules (2, 3,
15, 16, 27). In addition, the chromosome of B. burgdorfen is
linear (4, 5, 7, 12).
The DNA of eubacteria is in a state of torsional stress
termed negative supercoiling, in which the double helix is
slightly underwound (8, 9, 23, 30, 31). The degree of super-
coiling is modulated by the opposed activities of DNA
topoisomerase I and DNA gyrase, as well as by the tran-
scriptional machinery (8, 9, 18, 21). DNA gyrase catalyzes
the introduction of negative superhelical tension into DNA
(13, 23). The enzyme is a tetramer composed of two subunits
(A2B2): subunit A binds DNA and subunit B hydrolyzes ATP
(13, 23). DNA gyrase is required for bacterial DNA replica-
tion and functions in gene expression as well as other
elements of macromolecular DNA metabolism (8, 9, 21, 23,
30, 31).
Several antimicrobial agents specifically target DNA gy-
rase (10, 17, 22, 23, 32). We have investigated the activity of
coumermycin A1 and other DNA gyrase inhibitors on B.
burgdorferi because of our interest in probing the role of
DNA gyrase and understanding the structure of chromatin in
a bacterium with linear DNA molecules. We have found that
B. burgdorferi is susceptible to growth inhibition and circu-
lar plasmid relaxation by coumermycin.
MATERIALS AND METHODS
Bacteria and growth assay. B. burgdorfen B31 (the type
species, ATCC 35210) was grown at 34°C in BSK II medium
(1) lacking gelatin. This strain has been extensively passaged
in culture; it contains four linear plasmids (with sizes of 15.5,
27.1, 37.5 and 50.1 kb) and three covalently closed circular
plasmids (with sizes of 8, 26.2, and 29.3 kb) but no longer
* Corresponding author.
synthesizes a typical OspB protein (data not shown). Growth
was assayed by inoculating and growing 10-ml cultures,
centrifuging the cells, resuspending them in 1 ml of Dulbec-
co's phosphate-buffered saline (PBS), and determining the
optical density at 600 nm (1 unit of which was equivalent to
1.4 x 109 bacteria per ml) (26). The MIC was determined by
inoculating 10 ml of BSK II medium with 106 bacteria per ml
in the presence or absence of antibiotics, incubating the
mixture at 34°C until the cultures in the absence of antibiot-
ics reached approximately 1.5 x 108 bacteria per ml (usually
72 h), and assaying growth by determining the optical
density at 600 nm. MIC was defined as the concentration of
antibiotic that inhibited growth by 90% relative to growth in
the absence of antibiotic. At the MIC, there were no visual
signs of growth and no change in the color of the medium.
Antibiotics and enzymes. Coumermycin A1 (also referred
to as coumermycin; Sigma) at 50 mg/ml in dimethyl sulfoxide
(DMSO), novobiocin (Boehringer Mannheim) and ciproflox-
acin (Sigma) at 25 mg/ml in H20, and nalidixic acid (United
States Biochemical) and oxolinic acid (Sigma) at 50 mg/ml in
0.5 N NaOH were stored at -70°C. Antibiotics were added
directly to B. burgdorfen cultures inoculated with 106 bac-
teria per ml in BSK II medium, unless otherwise noted
(yielding a final DMSO concentration of 0.01%). Purified calf
thymus DNA topoisomerase I (30 U; GIBCO BRL) and
purified Micrococcus luteus DNA gyrase (20 U; GIBCO
BRL) were incubated with 20 ,ug of DNA for 1 h at 37°C in
20 ,ul of 40 mM Tris-HCl (pH 7.5)-15 mM KCl-10 mM
MgCl2-1.5 mM dithiothreitol-40 ,ug of bovine serum albumin
per ml. DNA gyrase and control reaction mixtures also
contained 1.5 mM ATP and 5 mM spermidine.
DNA purification. DNA was isolated from B. burgdorfien
by a modification of a previously described protocol (24).
Bacteria from 10-ml cultures were washed with 1 ml of PBS
and resuspended in 0.2 ml of 50 mM Tris-HCl (pH 8.0)-50
mM EDTA-15% sucrose. The cells were lysed by adding 23
pl of 10% sodium dodecyl sulfate and incubated at 37°C for
30 min after 3 pl of 20-mg/ml proteinase K solution was
added. The lysate was extracted once with an equal volume
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of phenol-chloroform-isoamyl alcohol (25:24:1). Nucleic
acid was precipitated by adding 8 ,ul of 5 M NaCl and 0.4 ml
of ethanol at -20°C. For some experiments, samples were
then treated with RNase A, extracted, and precipitated
again.
Agarose gel electrophoresis. The DNA was heated to 60°C
in 1% N-lauroylsarcosine-10 mM EDTA-3% Ficoll 400-0.05
mg of bromophenol blue per ml-0.05 mg of xylene cyanol per
ml for 2 min, cooled briefly, and fractionated on 0.35%
agarose gels (SeaKem GTG; FMC Bioproducts) in TAE (40
mM Tris, 20 mM acetate, 1 mM EDTA) at 12 V (0.4 V/cm)
for 48 h. The gels were stained in 0.5 ,ug of ethidium bromide
per ml for 1 h, destained in water for 1 h, visualized on a UJV
transilluminator (Foto UV 310; Fotodyne), and photo-
graphed through a 23A filter (series 7; Tiffen) and 5 mm of
UV opaque plexiglass (UviCover I; Fotodyne) with type 55
film (Polaroid). For the two-dimensional gel (20), DNA was
fractionated in the first dimension as described above except
that electrophoresis was carried out for 16 h. The gel was
then rotated 900 and equilibrated with 15 ,uM chloroquine in
TAE for 5 h. Electrophoresis was continued for 16 h in the
presence of 15 ,uM chloroquine. The gel was destained in
three changes of water (>1 h each) to remove chloroquine
before being stained with ethidium bromide. Molecular
weight standards were either lambda DNA-HindIII digest or
lambda DNA-Mono Cut Mix (New England BioLabs).
RESULTS
Inhibition of growth by coumermycin. Several gyrase in-
hibitors were examined for their effect on the growth of B.
burgdorferi in BSK II medium. Included were the DNA
gyrase subunit B inhibitors coumermycin and novobiocin, as
well as the subunit A inhibitors ciprofloxacin, nalidixic acid,
and oxolinic acid. B. burgdorferi B31 was found to be
particularly susceptible to coumermycin (Fig. 1), with a MIC
of 0.2 ,ug/ml. This degree of susceptibility was not seen with
nalidixic acid, oxolinic acid, or ciprofloxacin. Nalidixic acid
at 300 p,g/ml, the maximum concentration tested, inhibited
the relative growth of B. burgdorferi in BSK II medium by
only 50% (data not shown). The MICs of oxolinic acid,
ciprofloxacin, and novobiocin for B. burgdorferi B31 were
100, 2, and 5 ,ug/ml, respectively (data not shown).
Relaxation of supercoiled plasmids by slightly inhibitory
doses of coumermycin. Two-dimensional agarose gel electro-
phoresis was used to examine the effect of coumermycin on
plasmid DNA topology in B. burgdorferi, since coumermy-
cin treatment has previously been shown to induce the
relaxation of supercoiled DNA molecules in Escherichia coli
via inhibiting DNA gyrase (11, 14, 29). The second dimen-
sion was run in the presence of chloroquine, which unwinds
the helix and retards the migration of negatively supercoiled
closed circular DNA. The migration of linear DNA is not
affected by chloroquine, resulting in a diagonal pattern
following two-dimensional gel electrophoresis. This analysis
revealed the presence of two negatively supercoiled plas-
mids with approximate sizes of 26 and 29 kb (Fig. 2, lane 1).
The 8-kb supercoiled plasmid was not visualized in these
experiments. Treatment ofB. burgdorferi with coumermycin
induced the relaxation of these two plasmids (Fig. 2, lane 2).
DNA relaxation, the removal of superhelical tension, alters
the electrophoretic mobility of DNA molecules. The relaxed
form was not evident in this analysis but was demonstrated
by several criteria, including observation by electron micros-
copy (see below).
High concentrations of coumermycin induce DNA relax-
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FIG. 1. Effect of coumermycin on the growth of B. burgdorferi.
B. burgdorferi B31 was grown in BSK II medium containing various
concentrations of coumermycin. Plotted are the means of seven
independent experiments relative to no treatment for each experi-
ment. Two of the experiments included a 10-,ug/ml point, four
experiments had 0.3- and 3-p,g/ml points, five experiments had
0.0001-, 0.003-, and 0.03-,pg/ml points, six experiments included a
0.01->g/ml point, and all seven experiments contained 0.001-, 0.1-,
and 1-p.g/ml points. Error bars represent standard errors of the
means.
ation in E. coli, but low concentrations actually increase
supercoiling, because of increased DNA gyrase expression
(10). Plasmid relaxation, assayed in a conventional gel
electrophoresis system by the absence of the supercoiled
form, was induced by treatment of B. burgdorferi cells with
0.003 ,ug of coumermycin per ml (Fig. 3, lane 6), a dose that
only slightly inhibits growth (Fig. 1). However, we have not
observed increased supercoiling at any concentration of
kb
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FIG. 2. Effect of coumermycin on the topology of DNA in B.
burgdorferi. The topology ofDNA from B. burgdorferi B31 cultures
treated without (lane 1 [-]) or with (lane 2 [+]) 0.1 ,ug of coumer-
mycin per ml was determined by two-dimensional 0.35% agarose gel
electrophoresis and ethidium bromide staining. The supercoiled
forms of the 26- and 29-kb circular plasmids are indicated by arrows.
Molecular size markers (in kilobases) are indicated on the left.
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FIG. 3. Effect of coumermycin concentration on the relaxation
of supercoiled plasmids in B. burgdorferi. B. burgdorfen B31 was
grown in BSK II medium containing the following concentration
(p,g/ml) of coumermycin: 0 (lane 1), 0.00001 (lane 2), 0.0001 (lane 3),
0.0003 (lane 4), 0.001 (lane 5), 0.003 (lane 6), 0.01 (lane 7), or 0.1
(lane 8). DNA was isolated from these cultures, fractionated by
0.35% agarose gel electrophoresis, and stained with ethidium bro-
mide. The supercoiled forms of the 26- and 29-kb circular plasmids
are indicated by arrows. Molecular size markers (in kilobases) are
indicated on the left.
coumermycin tested from 0.00001 to 0.001 ,ug/ml (Fig. 3,
lanes 2 to 5, and data not shown), although we have not been
able to resolve individual topoisomers. Novobiocin, but not
ciprofloxacin, nalidixic acid, or oxolinic acid, also induced
the relaxation of the circular DNA molecules (data not
shown), consistent with the case for E. coli (10). Relaxation
was detectable within 1 h after the beginning of coumermy-
cin treatment (Fig. 4, lane 3) and was complete within 2 h
(Fig. 4, lane 4).
Supercoiling of relaxed plasmids in vivo and in vitro. We
employed four independent strategies to demonstrate that
the supercoiled plasmids were relaxed, rather than lost, after
coumermycin treatment. First, removing coumermycin from
the treated cultures by centrifugation and resuspension
resulted in resupercoiling of the relaxed plasmids in vivo
(Fig. 5). Plasmid supercoiling began at about 1 h (Fig. 5, lane
3) and was nearly complete after 2 h of chase (Fig. 5, lane 5).
This timing was similar to that for plasmid relaxation (Fig. 4)
and may reflect the kinetics of B. burgdorferi DNA gyrase in
vivo.
Second, DNA isolated from untreated cells and from cells
treated with slightly inhibitory doses of coumermycin was
treated with exogenous DNA topoisomerase I and exoge-
nous DNA gyrase (Fig. 6). DNA topoisomerase I can relax
supercoiled DNA but cannot supercoil DNA, while DNA
gyrase can supercoil DNA in an ATP-dependent fashion.
Purified DNA topoisomerase I relaxed the two negatively
supercoiled circular plasmids in vitro (Fig. 6, lanes 1 and 2),
resulting in the profile generated by coumermycin treatment
(Fig. 6, lane 4); this enzyme, however, had no effect on the
relaxed DNA from coumermycin-treated cells (Fig. 6, lane
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FIG. 4. Time course of coumermycin-induced relaxation of su-
percoiled plasmids in B. burgdorfen. B. burgdorferi B31 was not
treated (lane 1) or treated with 0.01 ,ug of coumermycin per ml for
0.5 h (lane 2), 1 h (lane 3), 2 h (lane 4), 3 h (lane 5), 4 h (lane 6), and
6 h (lane 7). DNA was analyzed by 0.35% agarose gel electrophore-
sis and stained with ethidium bromide. The supercoiled forms of the
26- and 29-kb circular plasmids are indicated by arrows. Molecular
size markers (in kilobases) are indicated on the left.
5). In contrast, DNA gyrase plus ATP had no effect on the
supercoiled plasmids (Fig. 6, lane 3) but was able to resu-
percoil in vitro the circular plasmids relaxed by coumermy-
cin treatment (Fig. 6, lanes 4 and 6). DNA gyrase did not
restore supercoiling to all of the circular plasmids of each
No
Chase time (h) 0 0.5 1 1.5 2 3 4 addition
kb
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FIG. 5. Time course of plasmid supercoiling in B. burgdorferi
after removal of coumermycin. B. burgdorfeni B31 grown in BSK II
medium with (lanes 1 to 7) or without (lane 8) 0.01 ,ug of coumer-
mycin per ml was centrifuged, resuspended in medium without
coumermycin, and incubated for 0 h (lane 1), 0.5 h (lane 2), 1 h (lane
3), 1.5 h (lane 4), 2 h (lane 5), 3 h (lane 6), or 4 h (lane 7). DNA was
resolved by 0.35% agarose gel electrophoresis and stained with
ethidium bromide. The supercoiled forms of the 26- and 29-kb
circular plasmids are indicated by arrows on the left. Molecular size
markers (in kilobases) are indicated on the left.
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FIG. 6. Effect of exogenous DNA topoisomerase I and DNA
gyrase on the topology of plasmids from B. burgdorferi. DNA
isolated from B. burgdorferi B31 treated with (lanes 4 to 6, labelled
+) or without (lanes 1 to 3, labelled -) 0.01 ,ug of coumermycin per
ml was incubated with ATP alone (lanes 1 and 4), purified DNA
topoisomerase I (Topo I; lanes 2 and 5), or ATP and purified DNA
gyrase (lanes 3 and 6). Reaction mixtures were subjected to 0.35%
agarose gel electrophoresis, and DNA was visualized by staining
with ethidium bromide. The supercoiled forms of the 26- and 29-kb
circular plasmids are indicated by arrows. Molecular size markers
(in kilobases) are indicated on the left.
size (Fig. 6, lanes 1 and 6), probably because relaxed
plasmids are more susceptible to nicking during isolation
than supercoiled plasmids, because of their less compact
conformation.
Third, electron microscopy of DNA preparations showed
that the circular DNA molecules were relaxed (19). Fourth,
the 29-kb circular plasmid was used to probe a Southern blot
of DNA from coumermycin-treated B. burgdorferi. This
experiment revealed that the relaxed form migrated with an
apparent size of approximately 50 kb, and visualization of
this 29-kb circular plasmid topoisomer by ethidium bromide
staining was obscured by the 50-kb linear plasmid (data not
shown).
DISCUSSION
B. burgdorferi was more susceptible to growth inhibition
and plasmid relaxation by coumermycin than were many
other bacteria (32). The MIC for susceptible strains of E. coli
is 15 ,ug/ml (14), making B. burgdorfen about 100 times more
susceptible. Unfortunately, coumermycin is not a clinically
useful antibiotic because of its insolubility, poor absorption,
and high serum inactivation (22). Further work on the
development of structural analogs that do not have these
problems may yield an effective treatment for Lyme disease.
B. burgdorferi was also susceptible to the coumarin antibi-
otic novobiocin but relatively resistant to the quinolone
antimicrobial agents. The MIC of nalidixic acid was greater
than 300 pg/ml for B. burgdorferi but only 8 pg/ml for E. coli,
and the MIC of ciprofloxacin was 100-fold higher for B.
burgdorferi than for E. coli (32). Preliminary results indi-
cated that E. coli was less susceptible to coumermycin,
oxolinic acid, and nalidixic acid (but not ciprofloxacin) in
BSK II medium than in Luria-Bertani medium (25).
The increased levels of supercoiling at low concentrations
of coumermycin that are found in E. coli (10) were not
observed in B. burgdorferi. Perhaps the genes encoding
DNA gyrase in B. burgdorferi are not regulated by super-
coiling, or the topology of the chromosome is not affected by
coumermycin treatment. In E. coli, coumermycin induces
DNA relaxation in 20 min, an interval nearly equal to the
generation time (11). In contrast, plasmid relaxation and
supercoiling in B. burgdorferi B31, an organism with a
generation time of approximately 12 h, required about 2 h.
Therefore, relaxation in B. burgdorferi does not appear to be
coupled directly to the replication cycle but may be mediated
by DNA topoisomerase I activity or active transcription.
Taken together, the results of these experiments suggest
that B. burgdorferi possesses a DNA gyrase that acts on the
circular DNA molecules and is required for growth. In
addition to providing a target for effective antimicrobial
agents, we currently are interested in whether DNA gyrase
also functions on the linear DNA molecules, where nearly all
genes mapped to date in B. burgdorferi are located. Coumer-
mycin will be used to dissect the mechanism of DNA
replication as well as the factors that influence the regulation
of gene expression.
ACKNOWLEDGMENTS
We thank Wai Mun Huang, Rich Marconi, Tom Schwan, and
especially Kit Tilly for thoughtful and critical reading of the manu-
script; Dave Dorward, Wai Mun Huang, Rich Marconi, Patti Rosa,
Tom Schwan, Kit Tilly (who suggested the experiment for which the
results are shown in Fig. 5), and the other members of LVP and the
RML Lyme group for valuable discussions; Dara Newman for help
with manuscript preparation; Bob Evans and Gary Hettrick for
figure preparation; and the anonymous reviewer for useful editorial
suggestions.
REFERENCES
1. Barbour, A. G. 1984. Isolation and cultivation of Lyme disease
spirochetes. Yale J. Biol. Med. 57:71-75.
2. Barbour, A. G. 1988. Plasmid analysis of Borrelia burgdorferi,
the Lyme disease agent. J. Clin. Microbiol. 26:475-478.
3. Barbour, A. G., and C. F. Garon. 1987. Linear plasmids of the
bacterium Borrelia burgdorferi have covalently closed ends.
Science 237:409-411.
4. Baril, C., C. Richaud, G. Baranton, and I. Saint Girons. 1989.
Linear chromosome of Borrelia burgdorferi. Res. Microbiol.
140:507-516.
5. Bergstrom, S., C. F. Garon, A. G. Barbour, and J. MacDougall.
1992. Extrachromosomal elements of spirochetes. Res. Micro-
biol. 143:623-628.
6. Burgdorfer, W., A. G. Barbour, S. F. Hayes, J. L. Benach, E.
Grunwaldt, and J. P. Davis. 1982. Lyme disease-a tick-borne
spirochetosis? Science 216:1317-1319.
7. Davidson, B. E., J. MacDougall, and I. Saint Girons. 1992.
Physical map of the linear chromosome of the bacterium Bor-
relia burgdorferi 212, a causative agent of Lyme disease, and
localization of rRNA genes. J. Bacteriol. 174:3766-3774.
8. Drlica, K. 1984. Biology of bacterial deoxyribonucleic acid
topoisomerases. Microbiol. Rev. 48:273-289.
9. Drlica, K. 1992. Control of bacterial DNA supercoiling. Mol.
Microbiol. 6:425-433.
10. Drlica, K., and R. J. Franco. 1988. Inhibitors of DNA topo-
isomerases. Biochemistry 27:2253-2259.
11. Drlica, K., and M. Snyder. 1978. Superhelical Escherichia coli
DNA: relaxation by coumermycin. J. Mol. Biol. 120:145-154.
12. Ferdows, M. S., and A. G. Barbour. 1989. Megabase-sized linear
DNA in the bacterium Borrelia burgdorfeni, the Lyme disease
VOL. 37, 1993
ANTIMICROB. AGENTS CHEMOTHER.
agent. Proc. Natl. Acad. Sci. USA 86:5969-5973.
13. Gellert, M. 1981. DNA topoisomerases. Annu. Rev. Biochem.
50:879-910.
14. Gellert, M., M. H. O'Dea, T. Itoh, and J.-I. Tomizawa. 1976.
Novobiocin and coumermycin inhibit DNA supercoiling cata-
lyzed by DNA gyrase. Proc. Natl. Acad. Sci. USA 73:4474-
4478.
15. Hinnebusch, J., and A. G. Barbour. 1991. Linear plasmids of
Borrelia burgdorferi have a telomeric structure and sequence
similar to those of a eukaryotic virus. J. Bacteriol. 173:7233-
7239.
16. Hyde, F. W., and R. C. Johnson. 1984. Genetic relationship of
Lyme disease spirochetes to Borrelia, Treponema, and Lepto-
spira spp. J. Clin. Microbiol. 20:151-154.
17. Liu, L. F. 1989. DNA topoisomerase poisons as antitumor
drugs. Annu. Rev. Biochem. 58:351-375.
18. Liu, L. F., and J. C. Wang. 1987. Supercoiling of the DNA
template during transcription. Proc. Natl. Acad. Sci. USA
84:7024-7027.
19. Lubke, L., D. S. Samuels, and C. F. Garon. Unpublished data.
20. Pruss, G. J. 1985. DNA topoisomerase I mutants: increased
heterogeneity in linking number and other replicon-dependent
changes in DNA supercoiling. J. Mol. Biol. 185:51-63.
21. Pruss, G. J., and K. Drlica. 1989. DNA supercoiling and
prokaryotic transcription. Cell 56:521-523.
22. Radl, S. 1990. Structure-activity relationships in DNA gyrase
inhibitors. Pharmacol. Ther. 48:1-17.
23. Reece, R. J., and A. Maxwell. 1991. DNA gyrase: structure and
function. Crit. Rev. Biochem. Mol. Biol. 26:335-375.
24. Rosa, P. A., and T. G. Schwan. 1989. A specific and sensitive
assay for the Lyme disease spirochete Borrelia bu,gdorfen
using the polymerase chain reaction. J. Infect. Dis. 160:1018-
1029.
25. Samuels, D. S., V. E. Tamplin, and D. W. Dorward. Unpub-
lished data.
26. Schwan, T. G., K. K. Kime, and D. S. Samuels. Unpublished
data.
27. Simpson, W. J., C. F. Garon, and T. G. Schwan. 1990. Analysis
of supercoiled circular plasmids in infectious and non-infectious
Borrelia burgdorferi. Microb. Pathog. 8:109-118.
28. Steere, A. C. 1989. Medical progress: Lyme disease. N. Engl. J.
Med. 9:586-596.
29. Sugino, A., N. P. Higgins, P. O. Brown, C. L. Peebles, and N. R.
Cozzarelli. 1978. Energy coupling in DNA gyrase and the
mechanism of action of novobiocin. Proc. Natl. Acad. Sci. USA
75:4838-4842.
30. Sutcliffe, J. A., T. D. Gootz, and J. F. Barrett. 1989. Biochemical
characteristics and physiological significance of major DNA
topoisomerases. Antimicrob. Agents Chemother. 33:2027-2033.
31. Wang, J. C. 1987. Recent studies of DNA topoisomerases.
Biochim. Biophys. Acta 909:1-9.
32. Zimmer, C., K. Stori, and J. Storl. 1990. Microbial DNA
topoisomerases and their inhibition by antibiotics. J. Basic
Microbiol. 30:209-224.
50 SAMUELS AND GARON
